Skip to content

PRevention of knee Osteoarthritis in Overweight Females (PROOF); long-term follow-up

PRevention of knee Osteoarthritis in Overweight Females (PROOF); long-term follow-up - PROOF study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41125
Enrollment
330
Registered
2014-08-20
Start date
2014-09-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis wear and tear

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Was participant in original trial. 2) Gave informed consent to be contacted for long-term follow-up at final measurements of the original trial.

Exclusion criteria

Exclusion criteria: No criteria excluding individuals who fulfill the inclusion criteria. Subjects with contra-indications for MRI will only be excluded for MRI measurements and subjects with bi-lateral total knee replacement will only be excluded for MRI and radiography.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the incidence of clinical knee osteoarthritis according to the 'clinical and radiologic ACR-criteria'

Secondary

MeasureTime frame
The secondary outcome measures are: - incidence of radiologic knee osteoarthritis (K&L >= 2) - incidence of joint space narrowing (JSN >= 1.0 mm) - progression of MRI features of knee osteoarthritis (MOAKS features) - WOMAC pain - WOMAC function - Quality of life - degenerative biomarkers in blood/urine

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)